Granules India shares climb nearly 7 pc on USFDA nod for drug
Shares of drug firm Granules India today soared nearly 7 per cent after the company's subsidiary received approval from the US health regulator for Methylergonovine tablets, used for prevention and control of postpartum haemorrhage.
The scrip advanced by 6.61 per cent to end at Rs 103.15
Disclaimer: No Business Standard Journalist was involved in creation of this content